Glenmede Trust Co. NA Sells 318 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)
Glenmede Trust Co. NA lessened its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,654 shares of the exchange traded fund’s stock after selling 318 shares during […]
More Stories
Standard Lithium (CVE:SLI) Trading Up 0.8% – Here’s Why
Shares of Standard Lithium Ltd. (CVE:SLI – Get Free Report) were up 0.8% on Thursday . The company traded as...
Nitori (OTC:NCLTY) Stock Price Down 0.6% – Time to Sell?
Nitori Holdings Co., Ltd. (OTC:NCLTY – Get Free Report)’s stock price fell 0.6% on Thursday . The company traded as...
Charlotte’s Web (TSE:CWEB) Trading Up 2.8% – Time to Buy?
Charlotte’s Web Holdings, Inc. (TSE:CWEB – Get Free Report)’s share price shot up 2.8% during trading on Thursday . The...
Urban Logistics REIT (OTC:PCILF) Stock Price Down 6.8% – Should You Sell?
Urban Logistics REIT plc (OTC:PCILF – Get Free Report) shares traded down 6.8% during mid-day trading on Thursday . The...
Titan Medical (NASDAQ:TMDIF) Stock Price Up 11.7% – What’s Next?
Titan Medical Inc. (NASDAQ:TMDIF – Get Free Report)’s share price traded up 11.7% during trading on Thursday . The stock...
iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF) Trading Down 0.1% – Here’s Why
iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF – Get Free Report)’s stock price were down 0.1% on Thursday . The...